JP2016500073A5 - - Google Patents

Download PDF

Info

Publication number
JP2016500073A5
JP2016500073A5 JP2015543098A JP2015543098A JP2016500073A5 JP 2016500073 A5 JP2016500073 A5 JP 2016500073A5 JP 2015543098 A JP2015543098 A JP 2015543098A JP 2015543098 A JP2015543098 A JP 2015543098A JP 2016500073 A5 JP2016500073 A5 JP 2016500073A5
Authority
JP
Japan
Prior art keywords
carboxamide
pyrazine
methyl
imidazo
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015543098A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016500073A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/070623 external-priority patent/WO2014078813A1/en
Publication of JP2016500073A publication Critical patent/JP2016500073A/ja
Publication of JP2016500073A5 publication Critical patent/JP2016500073A5/ja
Pending legal-status Critical Current

Links

JP2015543098A 2012-11-19 2013-11-18 寄生虫病の処置のための化合物および組成物 Pending JP2016500073A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261728024P 2012-11-19 2012-11-19
US61/728,024 2012-11-19
PCT/US2013/070623 WO2014078813A1 (en) 2012-11-19 2013-11-18 Compounds and compositions for the treatment of parasitic diseases

Publications (2)

Publication Number Publication Date
JP2016500073A JP2016500073A (ja) 2016-01-07
JP2016500073A5 true JP2016500073A5 (enExample) 2016-12-28

Family

ID=49667633

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015543098A Pending JP2016500073A (ja) 2012-11-19 2013-11-18 寄生虫病の処置のための化合物および組成物

Country Status (5)

Country Link
US (1) US20150291598A1 (enExample)
EP (1) EP2920177A1 (enExample)
JP (1) JP2016500073A (enExample)
CN (1) CN105189506A (enExample)
WO (1) WO2014078813A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2925757T1 (en) 2012-11-19 2018-01-31 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
CN105189506A (zh) * 2012-11-19 2015-12-23 诺华股份有限公司 用于治疗寄生虫疾病的化合物和组合物
JP6675334B2 (ja) * 2014-06-25 2020-04-01 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 脊髄性筋萎縮症を処置するためのイミダゾ[1,2−a]ピラジン−1−イルベンズアミド化合物
CN107108637B (zh) 2014-12-23 2019-10-29 诺华股份有限公司 三唑并嘧啶化合物及其用途
CN104610229B (zh) * 2015-01-21 2017-01-18 上海皓元生物医药科技有限公司 一种是atp竞争性小分子akt抑制剂a443654的合成方法
IL263429B (en) 2016-06-20 2022-08-01 Novartis Ag Crystalline forms of triazolopyrimidine compound
US10676479B2 (en) 2016-06-20 2020-06-09 Novartis Ag Imidazolepyridine compounds and uses thereof
WO2017221092A1 (en) 2016-06-20 2017-12-28 Novartis Ag Triazolopyridine compounds and uses thereof
GB201700692D0 (en) * 2017-01-16 2017-03-01 Salvensis Novel compounds and their use in the treatment of schistosomiasis
ES2951425T3 (es) * 2017-04-27 2023-10-20 Nihon Nohyaku Co Ltd Compuesto heterocíclico condensado o sal del mismo, insecticida agrícola y hortícola que comprende el compuesto o la sal, y método para usar el insecticida
WO2018237349A1 (en) * 2017-06-23 2018-12-27 University Of Washington Inhibitors of typed 1 methionyl-trna synthetase and methods of using them
US20200369665A1 (en) * 2017-06-30 2020-11-26 Ryvu Therapeutics S.A. Imidazo[1,2-a]pyrazine modulators of the adenosine a2a receptor
WO2019051642A1 (zh) * 2017-09-12 2019-03-21 广州中科蓝华生物科技有限公司 一种转染细胞内寄生虫的试剂盒及其应用
JP7377207B2 (ja) 2018-01-29 2023-11-09 メルク パテント ゲーエムベーハー Gcn2阻害剤およびその使用
US10239885B1 (en) 2018-06-18 2019-03-26 Avista Pharma Solutions, Inc. Compound 1-[2-[4-(2-ethyl-6,8-dimethylimidazo[1,2-α]pyrazin-3-yl)phenyl]ethyl]-3-(p-tolylsulfonyl)urea as a prostaglandin EP4 receptor antagonist
GB201811695D0 (en) 2018-07-17 2018-08-29 Salvensis Compounds for use in the treatment of fascioliasis
JP7309725B2 (ja) 2018-08-21 2023-07-18 杏林製薬株式会社 2環性ヘテロ芳香環誘導体
MX2021006696A (es) 2018-12-06 2021-07-07 Daiichi Sankyo Co Ltd Derivado de cicloalcano-1,3-diamina.
US11459331B2 (en) 2019-01-30 2022-10-04 Avista Pharma Solutions, Inc. Chemical compounds
EP3917935A4 (en) 2019-01-30 2022-11-16 Avista Pharma Solutions, Inc. SYNTHESIS PROCESS AND NEW INTERMEDIATES
CA3158333A1 (en) 2019-10-21 2021-04-29 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
WO2024022910A1 (en) 2022-07-26 2024-02-01 Syngenta Crop Protection Ag 1-[1-[2-(pyrimidin-4-yl)-1,2,4-triazol-3-yl]ethyl]-3-[2,4-dichloro-5-phenyl]urea derivatives and similar compounds as pesticides
EP4695244A1 (en) * 2023-04-13 2026-02-18 Syngenta Crop Protection AG Imidazo[1,2-a]pyridine derivatives
EP4695246A1 (en) * 2023-04-13 2026-02-18 Syngenta Crop Protection AG Imidazo[1,2-a]pyridine derivatives
AR132352A1 (es) * 2023-04-13 2025-06-18 Syngenta Crop Protection Ag Derivados de imidazo[1,2-a]pirazina
PY2426847A (es) * 2023-04-13 2025-03-20 Syngenta Crop Protection Ag Derivados bicíclicos de imidazo
WO2024213651A1 (en) * 2023-04-13 2024-10-17 Syngenta Crop Protection Ag Imidazo[1,2-a]pyridine derivatives
TW202446263A (zh) * 2023-04-13 2024-12-01 瑞士商先正達農作物保護股份公司 殺真菌組成物
WO2026018203A1 (en) * 2024-07-19 2026-01-22 Novartis Ag Aminoisoquinoline compounds and methods of using thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2514733A1 (en) 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
MX2009007944A (es) * 2007-01-26 2009-08-07 Irm Llc Compuestos y composiciones de purina como inhibidores de quinasa para el tratamiento de enfermedades relacionadas con plasmodium.
JO3156B1 (ar) * 2009-07-09 2017-09-20 Novartis Ag ايميدازولات مدمجة والتركيبات التي تشملها لعلاج الأمراض الطفيلية على مثال الملاريا
CN105189506A (zh) * 2012-11-19 2015-12-23 诺华股份有限公司 用于治疗寄生虫疾病的化合物和组合物

Similar Documents

Publication Publication Date Title
US11591336B2 (en) Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors
ES2968796T3 (es) Derivados de tiadiazolilo como inhibidores de la ADN polimerasa theta
ES2778700T3 (es) Nuevos derivados de piperidinilo sustituidos con (hetero)arilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
JP5864589B2 (ja) 細菌トポイソメラーゼii阻害性2−エチルカルバモイルアミノ−1,3−ベンゾチアゾール−5−イル類
JP2015522002A5 (enExample)
JP2017530960A5 (enExample)
RU2017105296A (ru) Новые соединения
JP2013508404A5 (enExample)
JP2020527560A5 (enExample)
JP2020514267A5 (enExample)
SI3177619T1 (en) 2- (morpholin-4-yl) -1,7-naphthyridines
JP2017510576A5 (enExample)
RU2016124178A (ru) Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
JP2017520607A (ja) 置換尿素誘導体及びその薬学的使用
JP2016500073A (ja) 寄生虫病の処置のための化合物および組成物
JP2016519096A5 (enExample)
CN111868037B (zh) 作为crhr2拮抗剂的稠合环状脲衍生物
JP2016507551A5 (enExample)
JP2014511355A5 (enExample)
JP2022505707A5 (enExample)
EP3390387A1 (en) Heteroarylbenzimidazole compounds
IL310330A (en) Compounds for the treatment of pain, in particular neuropathic pain, and/or other diseases or disorders that are associated with at2r and/or at2r mediated signaling
US20250230155A1 (en) 7,8-dihydro-5h-1,6-naphthyridine derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4 for treating neurological and psychiatric disorders
AU2023305453A1 (en) Tyrosine kinase 2 inhibitors and uses thereof
JP2024540874A5 (enExample)